Regeneron Pharmaceuticals Inc logo

REGN - Regeneron Pharmaceuticals Inc News Story

$516.62 -0.6  -0.1%

Last Trade - 14/05/21

Large Cap
Market Cap £39.22bn
Enterprise Value £38.64bn
Revenue £6.55bn
Position in Universe 223rd / 6851

Germany wants to use Regeneron's COVID-19 antibody therapy more broadly

Thu 15th April, 2021 9:12am
BERLIN, April 15 (Reuters) - Germany would like to use
Regeneron's  REGN.O  COVID-19 monoclonal antibody cocktail as a
treatment for this disease more broadly but needs to finalize
some details on reimbursement, Health Minister Jens Spahn said
on Thursday.
    "The drug is available in Germany, we need it much more and
we want it much more and we are working on rolling it out across
the nation," he told a weekly news conference.

 (Reporting by Caroline Copley, editing by Kirsti Knolle)
 ((; +49 (0)30 2201 33584 ;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.